These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9539095)
1. High-level endothelial expression of human CD59 prolongs heart function in an ex vivo model of xenograft rejection. Cowan PJ; Somerville CA; Shinkel TA; Katerelos M; Aminian A; Romanella M; Tange MJ; Pearse MJ; d'Apice AJ Transplantation; 1998 Mar; 65(6):826-31. PubMed ID: 9539095 [TBL] [Abstract][Full Text] [Related]
2. The pig analogue of CD59 protects transgenic mouse hearts from injury by human complement. Fisicaro N; Aminian A; Hinchliffe SJ; Morgan BP; Pearse MJ; D'Apice AJ; Cowan PJ Transplantation; 2000 Sep; 70(6):963-8. PubMed ID: 11014650 [TBL] [Abstract][Full Text] [Related]
3. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Kroshus TJ; Bolman RM; Dalmasso AP; Rollins SA; Guilmette ER; Williams BL; Squinto SP; Fodor WL Transplantation; 1996 May; 61(10):1513-21. PubMed ID: 8633381 [TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of alpha-1,2-fucosyltransferase, DAF, and CD59 in suppression of xenogenic immunological responses. Li SZ; Qu YC; Liu BQ; Wang GY; Zhang Y; Ma ZF; Ma TX; Qiu M; Han RF Xenotransplantation; 2009; 16(1):27-33. PubMed ID: 19243558 [TBL] [Abstract][Full Text] [Related]
5. Knock out of alpha1,3-galactosyltransferase or expression of alpha1,2-fucosyltransferase further protects CD55- and CD59-expressing mouse hearts in an ex vivo model of xenograft rejection. Cowan PJ; Chen CG; Shinkel TA; Fisicaro N; Salvaris E; Aminian A; Romanella M; Pearse MJ; d'Apice AJ Transplantation; 1998 Jun; 65(12):1599-604. PubMed ID: 9665076 [TBL] [Abstract][Full Text] [Related]
6. High-level co-expression of complement regulators on vascular endothelium in transgenic mice: CD55 and CD59 provide greater protection from human complement-mediated injury than CD59 alone. Cowan PJ; Shinkel TA; Aminian A; Romanella M; Wigley PL; Lonie AJ; Nottle MB; Pearse MJ; d'Apice AJ Xenotransplantation; 1998 Aug; 5(3):184-90. PubMed ID: 9741456 [TBL] [Abstract][Full Text] [Related]
7. Contrast in the efficacy of hDAF mouse hearts between ex vivo perfusion and transplantation into primates. Verbakel CA; de Bruin RW; Bonthuis F; Jonker M; Dekker S; Marquet RL; IJzermans JN Xenotransplantation; 2001 Nov; 8(4):284-91. PubMed ID: 11737854 [TBL] [Abstract][Full Text] [Related]
8. Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice. Byrne GW; McCurry KR; Kagan D; Quinn C; Martin MJ; Platt JL; Logan JS Transplantation; 1995 Nov; 60(10):1149-56. PubMed ID: 7482724 [TBL] [Abstract][Full Text] [Related]
9. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion. McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395 [TBL] [Abstract][Full Text] [Related]
10. Transgenic expression of human alpha1,2-fucosyltransferase (H-transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection. Chen CG; Salvaris EJ; Romanella M; Aminian A; Katerelos M; Fisicaro N; d'Apice AJ; Pearse MJ Transplantation; 1998 Mar; 65(6):832-7. PubMed ID: 9539096 [TBL] [Abstract][Full Text] [Related]
11. [Coexpression of human complement regulatory protein genes, CD59 and MCP in transgenic mice protects isolated mouse heart function in ex vivo human plasma perfusion model]. Xie L; Zhu M; Wang SS; Li R; Zeng MH; Huang YB; Wang L; Guo H; Wei QX; Li WX; Chen S Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):3001-4. PubMed ID: 16324389 [TBL] [Abstract][Full Text] [Related]
14. Human CD59 expressed in transgenic mouse hearts inhibits the activation of complement. Diamond LE; McCurry KR; Oldham ER; Tone M; Waldmann H; Platt JL; Logan JS Transpl Immunol; 1995 Dec; 3(4):305-12. PubMed ID: 8665149 [TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against hyperacute rejection. Niemann H; Verhoeyen E; Wonigeit K; Lorenz R; Hecker J; Schwinzer R; Hauser H; Kues WA; Halter R; Lemme E; Herrmann D; Winkler M; Wirth D; Paul D Transplantation; 2001 Dec; 72(12):1898-906. PubMed ID: 11773886 [TBL] [Abstract][Full Text] [Related]
16. Expression and functional analysis of glycosyl-phosphatidyl inositol-linked CD46 in transgenic mice. Shinkel TA; Cowan PJ; Barlow H; Aminian A; Romanella M; Lublin DM; Pearse MJ; d'Apice AJ Transplantation; 1998 Dec; 66(11):1401-6. PubMed ID: 9869079 [TBL] [Abstract][Full Text] [Related]
17. Functional activity of the membrane-associated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection. Heckl-Ostreicher B; Binder R; Kirschfink M Clin Exp Immunol; 1995 Dec; 102(3):589-95. PubMed ID: 8536377 [TBL] [Abstract][Full Text] [Related]
18. The role of natural IgM in the hyperacute rejection of discordant heart xenografts. Gambiez L; Salame E; Chereau C; Calmus Y; Cardoso J; Ayani E; Houssin D; Weill B Transplantation; 1992 Oct; 54(4):577-83. PubMed ID: 1412747 [TBL] [Abstract][Full Text] [Related]
19. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Diamond LE; Quinn CM; Martin MJ; Lawson J; Platt JL; Logan JS Transplantation; 2001 Jan; 71(1):132-42. PubMed ID: 11211178 [TBL] [Abstract][Full Text] [Related]